PULSE BIOSCIENCES, INC. — Director's Dealing 2023

May 10, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2023-05-09

Reporting Person: DUGGAN ROBERT W (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-05-09	Common Stock	P	10022937	$6.51	Acquired	30414661	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	411044	Indirect

Footnotes

F1: Shares were acquired pursuant to the terms of that certain purchase agreement by and between the Reporting Person and the Issuer, of which consideration included the satisfaction of a loan from the Reporting Person to the Issuer.

F2: Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.